Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Five years ago, and to his enduring credit, Louisiana Sen. Bill Cassidy voted to convict Donald Trump on an impeachment ...
Replit is racing to turn its AI coding tools into a full-stack software factory, and investors appear ready to bankroll that ambition at massive scale. The company is seeking a fresh $400 million ...
Like all AI models based on the Transformer architecture, the large language models (LLMs) that underpin today’s coding ...